Enrolling By InvitationNCT05368493
Official study titlePrenatal Air Pollution and Neurodevelopment: a Longitudinal Neuroimaging Study of Mechanisms and Early Risk for ADHD in Puerto Rican Children
This study is by invitation only.
Multiple locations, including New YorkADHDInterventional studyAges 6 months–11 years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
Enrolling By InvitationNCT07316387
Official study titleNeurobehavioral Development in Toddlers and Preschoolers in Relation to Prenatal Exposure of Mild Analgesics
This study is by invitation only.
In CopenhagenADHDObservational studyAges 2–6
- Countries
- Denmark
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Not recruitingISRCTN91988877
This study isn't currently recruiting.
In NorwayADHDResearch studyAges 18+
- Countries
- Norway
- Sponsor
- University of Bergen
Not recruitingISRCTN15281572
This study isn't currently recruiting.
In United KingdomADHDResearch study
- Countries
- United Kingdom
- Sponsor
- University College London
Not recruitingISRCTN17402196
This study isn't currently recruiting.
In United KingdomADHDResearch study
- Countries
- United Kingdom
- Sponsor
- Pennine Care NHS Foundation Trust
CompletedNCT00500149
Official study titleA Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Shire
CompletedNCT04002167
Official study titleA Novel Neuromonitoring Guided Cognitive Intervention for Targeted Enhancement of Working Memory
This study has finished and is no longer accepting participants.
In StanfordADHDBehavioural studyAges 7–11
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT03066505
Official study titleA Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With Attention Deficit Hyperactivity Disorder.
This study has finished and is no longer accepting participants.
In Los AngelesADHDDevice studyAges 18–25
- Countries
- United States
- Sponsor
- Wave Neuroscience
CompletedNCT01364662
What is this study about?This study evaluated the safety and effectiveness of SPN-810 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
CompletedNCT06359899
What is this study about?This study evaluated the safety and effectiveness of AK0901 capsule for people with ADHD.
This study has finished and is no longer accepting participants.
In BeijingADHDMedication studyAges 6–12
- Countries
- China
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
CompletedNCT05417607
Official study titleSub-study: Feasibility Trial of Adapted ESDM-informed Caregiver Coaching Delivered Remotely for Children With ASD and ADHD
This study has finished and is no longer accepting participants.
In DurhamADHDBehavioural studyAges 36–131 months
- Countries
- United States
- Sponsor
- Duke University
TerminatedNCT00852059
Official study titleEffect of Methylphenidate Formulation on ADHD-patients' Adherence to Medical Treatment. A Comparison of Medikinet Retard® (ER) Once Daily and Medikinet® (IR) Twice Daily in Children and Adolescents Diagnosed With ADHD
This study ended early.
In MainzADHDMedication studyAges 6–17
- Countries
- Germany
- Sponsor
- Prof. Huss